FLT3 and acute myeloid leukemia: NPM1 mutation is favorable prognostic factor in AML patients in the absence of FLT3-ITD mutation.[19,20] However, hypocellular AML patients had significantly lower rate of both NPM1 mutation and FLT3-ITD mutation in this study.